iX Biopharma has been granted a patent in Israel for its WaferiX drug delivery technology. The patent will expire on October 11, 2033, and will provide key intellectual property protection for the company's WaferiX delivery technology platform in Israel.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply